Amphastar Pharmaceuticals, Inc. (AMPH) Stock Overview
Explore Amphastar Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Amphastar Pharmaceuticals, Inc. (AMPH)
Key Financials
Key Financials
Market Cap
1.1B
P/E Ratio
13.62
EPS (TTM)
$2.93
ROE
0.10%
AMPH Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Amphastar Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of AMPH on the NASDAQ shows an RSI of 76.50, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $12.85 for the NASDAQ listing.
Key metrics behind Amphastar Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of 13.62 and a market capitalization of 1.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AMPH on the NASDAQ.